Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 8:50 p.m.

    📋 TriSalus Life Sciences Inc (TLSIW) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 07:09:19

    Event Type: Clinical Trial Update

    Event Details:

    TriSalus Life Sciences Inc (TLSIW) Announces Clinical Trial Update TriSalus Life Sciences Inc (TLSIW) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: outcomes, results
    • Collaboration: TriSalus
    • Updated Timeline: Year-Over-YearFull-year 2025, full-year 2025

    🔬 Clinical Development Pipeline (TriSalus Life Sciences Inc):

    Product Type Development Stage Therapeutic Area Source
    TriNaV DEVICE Approved Uterine Bleeding ClinicalTrials.gov
    Stereotactic Body Radiation Therapy RADIATION Phase PHASE2 Prostatic Neoplasms ClinicalTrials.gov
    Prednisone DRUG Phase PHASE2 Prostatic Neoplasms ClinicalTrials.gov
    Abiraterone Acetate DRUG Phase PHASE2 Prostatic Neoplasms ClinicalTrials.gov
    Leuprolide acetate DRUG Phase PHASE2 Prostatic Neoplasms ClinicalTrials.gov
    SD-101 DRUG Phase PHASE2 Prostatic Neoplasms ClinicalTrials.gov
    Pembrolizumab DRUG Phase PHASE2 Prostatic Neoplasms ClinicalTrials.gov
    Ipilimumab BIOLOGICAL Phase PHASE1 Hepatocellular Carcinoma ClinicalTrials.gov
    Nivolumab BIOLOGICAL Phase PHASE1 Hepatocellular Carcinoma ClinicalTrials.gov
    Nivolumab and Relatlimab BIOLOGICAL Phase PHASE1 Metastatic Uveal Melanoma in the Liver ClinicalTrials.gov
    PEDD device DEVICE Approved Liver Cancer ClinicalTrials.gov
    Standard microcatheter DEVICE Approved Liver Cancer ClinicalTrials.gov
    TriSalus Infusion System DEVICE Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    FOLFIRINOX DRUG Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    FOLFIRI DRUG Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Data Collection OTHER Preclinical Hyperthyroidism; Goiter ClinicalTrials.gov
    TACE Catheters DEVICE Approved Hepatocellular Carcinoma ClinicalTrials.gov
    Durvalumab DRUG Phase PHASE1 Hepatocellular Carcinoma ClinicalTrials.gov
    Tremelimumab DRUG Phase PHASE1 Hepatocellular Carcinoma ClinicalTrials.gov
    Cryotherapy DEVICE Phase PHASE1 Hepatocellular Carcinoma ClinicalTrials.gov
    anti-PD-1 BIOLOGICAL Phase PHASE1 Locally Advanced Pancreatic Adenocarcinoma ClinicalTrials.gov
    Y90-radioembolization procedure PROCEDURE Approved Liver Cancer ClinicalTrials.gov
    TriSalus™ TriNav™Infusion System DEVICE Approved Liver Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: TriSalus Life Sciences Inc
    • Ticker Symbol: TLSIW

Search

News categories